Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
4
×
boston
boston blog main
boston top stories
clinical trials
life sciences
national blog main
4
×
national top stories
atlas venture
deals
gene therapy
new york blog main
san francisco blog main
startups
adeno-associated virus
alexion pharmaceuticals
allosteric
alnylam pharmaceutials
arrowhead pharmaceuticals
astellas pharma
atopic dermatitis
audentes therapeutics
autoimmune disorders
avidity biosciences
bluebird bio
boehringer ingelheim
brace pharma
cancer
chemotherapy
cisplatin
cleva pharma
decibel therapeutics
dicerna pharmaceuticals
drug discovery
duchenne muscular dystrophy
dupilumab
dyne therapeutics
eli lilly
facioscapulohumeral muscular dystrophy
glaxosmithkline
What
ago
4
×
medicines
4
×
therapeutics
long
years
abandoning
adding
address
adds
aiming
allosteric
baggage
balance
biotechs
build
clinic
companies
considering
cuts
data
deal
decibel
development
dicerna
disease
diseases
drug
drugs
dyne
early
elusive
emerged
expected
experimental
eyes
focus
forms
free
genetic
gets
Language
unset
Current search:
medicines
×
biotech
×
" national blog main "
×
ago
×
@xconomy.com
3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@xconomy.com
4 years ago
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic
@xconomy.com
4 years ago
Decibel Therapeutics Strikes a Balance, Adding Regenerative Med Focus
@xconomy.com
5 years ago
Free of Baggage, Dicerna Cuts Another RNAi Deal and Gets $200M